Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Robert Wright

Clinical Assistant Professor

Canada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

About

Robert Wright is a Clinical Assistant Professor at the Faculty of Pharmaceutical Sciences, University of British Columbia. His research focuses on viral infections and their treatment, notably in the context of transplantation and chronic hepatitis C virus infection. His recent publications include studies on T-cell therapy for cytomegalovirus and the implementation of virtual health care during the COVID-19 pandemic.

Articles (7)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2023

Year:

2020

Year:

2020

Collaborators (2)

Christine M. Durand

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Robin Avery

Professor of Medicine

Johns Hopkins University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Wright

Research Interests

Make your next move.

Explore related searches

About

Articles (7)

Early CMV-specific T cell immune reconstitution after kidney transplantation: A prospective AIM-based cohort study

Impact of Epstein‐Barr Virus Donor Serostatus on Post‐Transplant Mortality and Post‐Transplant Lymphoproliferative Disorder in Epstein‐Barr Virus Seropositive Thoracic Organ Transplant Recipients: Data from the Organ Procurement and Transplantation Network

Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network

Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review

Therapy interruptions and drug interactions during acute hospitalization in patients taking direct acting antivirals for chronic hepatitis C virus infection: a retrospective cross-sectional study

Necessity is the mother of invention: Rapid implementation of virtual health care in response to the COVID‐19 pandemic in a lung transplant clinic

Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents.

Collaborators (2)

Christine M. Durand

Robin Avery

Make your next move.